Huntsman Cancer Institute joins with other institutions through myeloMATCH, a program that matches patients with clinical trials that specifically target their disease.
An associate professor in the division of hematology and hematopoietic malignancies, Buckley has been tapped to lead a program focused on cancer biology and how healthy cells transform into cancer.
Read about cutting-edge cancer research centered around elephant genes, a new clinical trial, and grants to study vaccination hesitance in the Mountain West as well as chronic lymphocytic leukemia.
Many dry shampoo brands are under voluntary recall after the FDA found many contained a carcinogen called benzene. Learn more about benzene, why it’s harmful, and your risk of exposure.
Elise Mahaffie was diagnosed with chronic lymphocytic leukemia a decade ago. Her cancer journey has taken her all over the United States. Now living in Wyoming, she makes the trek...
Huntsman Cancer Institute celebrates the addition of two endowed chair holders and a fellowship, as well as the renewal of two esteemed endowed chairs. CEO Mary Beckerle, PhD, congratulates distinguished...
A national authority in hematology will soon lead Hematology and Hematological Malignancies at Huntsman Cancer Institute and Ï㽶ÊÓƵ of Utah Health. Dr. Ramiro Garzon's focus is patients with leukemia and...
A unique collection of tissue samples donated by people with chronic myeloid leukemia was the driving force behind the discovery of a potentially major new treatment approach for drug-resistant leukemia...
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection accurately identified all patients who would eventually relapse, while other methods were...
Adam Whitt shares experiences about being a professional baseball pitcher and then being diagnosed with chronic myeloid (or myelogenous) leukemia. Now in remission, he is finding success in another sport—golf.
New research published today in JAMA Oncology reports how two separate DNA changes appear to predict aggressive childhood leukemias when they occur in combination. This study illuminates genetic understanding of...
Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG...
HCI physician-scientist Ami Patel, MD, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award for her research in leukemia. ASH Scholar Awards are one...
Kenneth Slack knows the pain of losing a spouse to cancer. He and his wife, Debby, were expecting to spend 60 or 70 years together, but they only got 32...
Tsewang Tashi., MD, is hematologist and an assistant professor in the division of hematology and hematologic malignancies at the Ï㽶ÊÓƵ of Utah. He sees patients at HCI, South Jordan Health...
